Predisposing Factors and Treatment Outcome of Otomycosis

Authors

  • Arifullah ., Dr. Town Teaching Hospital, Peshawar, Pakistan
  • Syed Zafar Hassan, Dr. District Hospital Kohat, Pakistan
  • Israr -Ud- Din, Dr. Khyber Teaching Hospital, Peshawar, Pakistan

DOI:

https://doi.org/10.37762/jgmds.2-2.53

Keywords:

Otomycosis

Abstract

OBJECTIVES:
The aim of this study was to determine the predisposing factors and treatment outcomes of otomycosis.
METHODS:
This was an observational study conducted from July 2008 to August 2012 at ENT department of Khyber Teaching Hospital, Peshawar. Total of 110 patients of all age and both sexes were selected from OPD for the study, using convenient sampling. The predisposing factors and treatment outcome of otomycosis were observed. Results were recorded in percentages.
RESULTS:
In our study we documented 110 patients having otomycosis. There were 57.3% (63/110) males and 42.7% (47/110) females. Patients ranged from 21 to 40 years were more affected. Mean follow up time was 2 years. The most common predisposing factors were swimming in 49.1% (54/110) patients followed by topical antibiotic drops, cerumen, immune-compromised status and hearing aid use. The most common presenting symptom was otalgia and itching ear in almost every patient 100% (110/110), followed by hearing loss and ear discharge. In our study 1% clotrimazole drops or lotion was applied to all patients after cleaning the fungus debris and cleansing the ear with acetic acid. The treatment outcome was resolution in 57.3%, residual 24.5% and recurrence 12.7%. 5.5% of patients did not come for follow up. The complications were TM perforation in 13.6% patients, serous otitis media in 3.6% and external auditory canal osteitis in 0.9%.
CONCLUSION:
Otomycosisis usually resolves with local toilet of ear and instillation of antifungal agents, however eradication of disease is difficult in presence of a mastoid cavity and immune-compromised patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied

Mahmoudabadi AZ. Mycological Studies in 15 cases of otomycosis. Pak J Med Sci. 2006;22(4):486–488

Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolyryngology in tribhuvan university teaching Hospital, Kathmandu, Nepal. Ann OtolRhinolLaryngol. 2003;112(4):384–387 DOI: https://doi.org/10.1177/000348940311200416

Satish H et al; A Clinical Study of Otomycosis. IOSR Journal of Dental and Medical Sciences. 2013 May: 5(2):2279-0861 DOI: https://doi.org/10.9790/0853-0525762

Ford ES, Mokdad AH, Giles WH. Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviours. Obes Res. 2005;13(1):118–122 DOI: https://doi.org/10.1038/oby.2005.15

Jackman A, Ward R, April M, Bent J. Topical antibiotic induced otomycosis. Int J PediatrOtorhinolaryngol. 2005;69(6):857–860 DOI: https://doi.org/10.1016/j.ijporl.2005.01.022

Kujundzic M, Braut T, Manestar D et al; Water related otitis externa. CollAntropol. 2012 Sep;36(3):893-7

Latha R, Sasikala R, Muruganandam N; Chronic otomycosis due to malassezia spp. J Glob Infect Dis. 2010 May;2(2):189-90 DOI: https://doi.org/10.4103/0974-777X.62875

Vennewald I, Klemm E; Otomycosis: Diagnosis and treatment. ClinDermatol. 2010 Mar 4;28(2):202-11 DOI: https://doi.org/10.1016/j.clindermatol.2009.12.003

Ho T, Vrabec JT, Yoo D, et al; Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006 Nov;135(5):787-91 DOI: https://doi.org/10.1016/j.otohns.2006.07.008

Abou-Halawa AS, Khan MA, Alrobaee AA, et al; Otomycosis with Perforated Tympanic Membrane: Self medication with Topical Antifungal Solution versus Medicated Ear Wick. Int J Health Sci (Qassim). 2012 Jan;6(1):73-7. DOI: https://doi.org/10.12816/0005975

Gharaghani M1, Seifi Z, ZareiMahmoudabadiA.Otomycosis in iran: a review.Mycopathologia. 2015 Jun;179(5-6):415-24 DOI: https://doi.org/10.1007/s11046-015-9864-7

Prasad SC, Kotigadde S, Shekhar M, et al. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.Int J Microbiol. 2014;2014:636493 DOI: https://doi.org/10.1155/2014/636493

Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014 May;30(3):564-7 DOI: https://doi.org/10.12669/pjms.303.4106

Khan F, Muhammad R, Rehman F, Iqbal J, ,Ullah G. Efficacy of topical clotrimazole in treatment of otomycosis. J Ayub Med CollAbbottabad. 2013 Jan-Jun;25(1-2):78-80

Ologe FE1, Nwabuisi C. Treatment outcome of otomycosis in Ilorin, Nigeria. West Afr J Med. 2002 Jan-Mar;21(1):34-6

Hurst WB. Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol. 2001 Nov;115(11):879-80 DOI: https://doi.org/10.1258/0022215011909486

Downloads

Published

2016-03-01

How to Cite

., A., Hassan, S. Z., & Din, I. .-U.-. (2016). Predisposing Factors and Treatment Outcome of Otomycosis. Journal of Gandhara Medical and Dental Science, 2(2), 27–31. https://doi.org/10.37762/jgmds.2-2.53

Similar Articles

You may also start an advanced similarity search for this article.